modafinil will minimize the level or outcome of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. tecovirimat will improve the level or outcome of modafinil by affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Watch. Tecovirimat is really a weak inhibitor of CYP2C8 and CYP2C19. Observe for adverse consequences if coadministered https://modafinil77653.blogitright.com/26201335/detailed-notes-on-modafinil